Fresh2 Group (ANPC) Stock Price, News & Analysis

Company Overview

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Key Stats

• Today's Range: $4.25 to $4.65
• 50-Day Range: $3.99 to $7.40
• 52-Week Range: $2.60 to $11.99
• Volume: 35,700 shs
• Average Volume: 26,396 shs
• Market Capitalization: $4.24 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ANPC Stock Analysis - Frequently Asked Questions

When did Fresh2 Group's stock split?

Fresh2 Group's stock reverse split before market open on Friday, November 4th 2022. The 1-20 reverse split was announced on Friday, November 4th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 4th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Fresh2 Group IPO?

Fresh2 Group (ANPC) raised $22 million in an IPO on the week of January 13th 2020. The company issued 1,700,000 shares at $12.00-$14.00 per share. WestPark Capital and Univest Securities acted as the underwriters for the IPO.

What other stocks do shareholders of Fresh2 Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresh2 Group investors own include Exxon Mobil (XOM), Acorda Therapeutics (ACOR), Chevron (CVX), Pfizer (PFE), American Airlines Group (AAL), Applied Genetic Technologies (AGTC) and Ashford Hospitality Trust (AHT).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical laboratories
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ANPC
• CUSIP: N/A
• CIK: 1786511
• Web: www.anpacbio.com
• Phone: 86-57-8205-1666
• Fax: N/A
• Employees: 86
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.32
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: $1.75 million
• Price / Sales: 2.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.41) per share
• Price / Book: -3.10

Miscellaneous

• Outstanding Shares: 970,000
• Free Float: 715,000
• Market Cap: $4.24 million
• Optionable: Not Optionable
• Beta: 1.55